ElizabethSKaufmanMD

PubMed

• 3 citations
  Clinical Management of Brugada Syndrome: Commentary From the Experts.
  Michael J Cutler, Lee L Eckhardt, Elizabeth S Kaufman, Elena Arbelo, Elijah R Behr
  Circulation. Arrhythmia and Electrophysiology. 2024-01-01
• 1447 citations
  Subclinical Atrial Fibrillation and the Risk of Stroke
  Jeff S. Healey, Stuart J. Connolly, Michael R. Gold, Carsten W. Israel, Isabelle C. Van Gelder
  The New England Journal of Medicine. 2012-01-11
• 152 citations
  European Heart Rhythm Association (EHRA)/Heart Rhythm Society (HRS)/Asia Pacific Heart Rhythm Society (APHRS)/Latin American Heart Rhythm Society (LAHRS) Expert Consen...
  Arthur A M Wilde, Christopher Semsarian, Manlio F Márquez, Alireza Sepehri Shamloo, Michael J Ackerman
  Journal of Arrhythmia. 2022-08-01

Journal Articles

• Risk of life threatening cardiac events among patients with long QT syndrome and multiple mutations.  
  Mullally J, Goldenberg I, Moss AJ, Lopes CM, Ackerman MJ, Zareba W, McNitt S, Robinson JL, Benhorin J, Kaufman ES, Towbin JA, Barsheshet A, Heart Rhythm 2013;10:378-382, 2013
• Combined assessment of sex- and mutation-specific information for risk stratification in type 1 long QT syndrome.  
  Costa J, Lopes CM, Barsheshet A, Moss AJ, Migdalovich D, Ouellet G, McNitt S, Polonsky S, Robinson JL, Zareba W, Ackerman MJ, Benhorin J, Kaufman ES, Platonov PG, Shim..., Heart Rhythm 2012;9:892-898, 2012
• Age and gender modification of the long QT syndrome phenotype.  
  Ziv O, Kaufman ES, Cardiology Electrophysiology Clinics 2012;4:39-51, 2012
• Risk factors for recurrent syncope and subsequent fatal or near-fatal events in children and adolescents with long QT syndrome.  
  Liu JF, Jons C, Moss AJ, McNitt S, Peterson DR, Qi M, Zareba W, Robinson JL, Barsheshet A, Ackerman MJ, Benhorin J, Kaufman ES, Locati EH, Napolitano C, Priori SG, Sch..., J Am Coll Cardiol 2011;57:941-950, 2011
• Beta-blockers reduce global dispersion of repolarization during exercise in normal subjects.  
  Gemma LW, Ward GM, Dettmer MM, Ball JL, Leo PJ, Doria DN, Kaufman ES, Heart Rhythm 2011;8:S276-277, 2011
• International LQTS Registry Investigators. Beta-blocker efficacy in high-risk patients with the congenital long-QT syndrome types 1 and 2: implications for patient man...  
  Goldenberg I, Bradley J, Moss A, McNitt S, Polonsky S, Robinson JL, Andrews M, Zareba W, J Cardiovasc Electrophysiol 2010;21:893-901, 2010
• Influence of diabetes mellitus on outcome in patients over 40 years of age with the long QT syndrome.  
  Ouellet G, Moss AJ, Jons C, McNitt S, Mullally J, Fugate T, Goldenberg I, Zareba W, Robinson JL, Am J Cardiol 2010;105:87-89, 2010
• Utility of Genetic Testing in Long QT Syndrome.  
  Kaufman ES, Circulation 2010;121:e439, 2010
• The future of fellowship training in clinical cardiac electrophysiology: program directors’ perspective 2008.  
  Chugh SS, Donahue JK, Kaufman ES, Link MS, Markowitz SM, Narayan SJ, Quan KJ, Tomaselli GF, Heart Rhythm 2009;6:1606-1612, 2009
• Long QT syndrome in patients over 40 years of age: increased risk for LQTS-related cardiac events in patients with coronary disease.  
  Sze E, Moss AJ, Goldenberg I, McNitt S, Jons C, Zareba W, Qi M, Robinson JL, Ann Noninvasive Electrocardiol 2008;13:327-331, 2008
• Risk of cardiac events in patients with asthma and long-QT syndrome treated with beta(2) agonists.  
  Thottathil P, Acharya J, Moss AJ, Jons C, McNitt S, Goldenberg I, Zareba W, Kaufman E, Qi M, Robinson JL, Am J Cardiol 2008;102:871-874, 2008
• An “indeterminate” microvolt T-wave alternans test predicts high mortality risk in patients with impaired left ventricular function.  
  Kaufman ES, Bloomfield DM, Steinman RC, Namerow PB, Costantini O, Cohen RJ, Bigger JT, J Am Coll Cardiol 2006;48:1399-1404, 2006
• Occurrence and characteristics of stroke events in the Atrial Fibrillation Follow-up Investigation of Sinus Rhythm Management (AFFIRM) study.  
  Sherman DG, Kim SG, Boop BS, Corley SD, DiMarco JP, Hart RG, Haywood LJ, Hoyte K, Kaufman ES, Kim MH, Nasco E, Waldo AL, Arch Intern Med 2005;165:1185-1191, 2005
• AHA scientific statement: practice standards for electrocardiographic monitoring in hospital settings: an American Heart Association Scientific Statement from the Coun...  
  Drew BJ, Califf RM, Funk M, Kaufman ES, Krucoff MW, Laks MM, Macfarlane PW, Sommargren C, Swiryn S, Van Hare GF, J Cardiovasc Nurs 2005;20:76-106, 2005
• Proarrhythmic events in atrial fibrillation: a multivariate analysis of the AFFIRM study.  
  Kaufman ES, Zimmermann PA, Wang T, Dennish GW, Barrell PD, Chandler ML, Greene HL for the AFFIRM Investigators., Cardiology Review 2005;22:18-21, 2005
• Practice standards for electrocardiographic monitoring in hospital settings: a report for healthcare professionals by a task force of American Heart Association Counci...  
  Drew BJ, Califf RM, Funk M, Kaufman ES, Krucoff MW, Laks MM, Macfarlane PW, Sommargren C, Swiryn S, Van Hare GF, Circulation 2004;110:2721-2746, 2004
• Risk of proarrhythmic events in the AFFIRM study: a multivariate analysis.  
  Kaufman ES, Zimmermann PA, Wang T, Dennish GW, Barrell PD, Chandler ML, Greene HL, J Am Coll Cardiol 2004;44:1276-1282, 2004
• Location of mutation in the KCNQ1 and phenotypic presentation of long QT syndrome.  
  Zareba W, Moss AJ, Sheu G, Kaufman ES, Priori S, Vincent GM, Towbin JA, Benhorin J, Schwartz PJ, Napolitano C, Hall WJ, Keating MT, Qi M, Robinson JL, Andrews ML, J Cardiovasc Electrophysiol 2003;14:1149-1153, 2003
• Electrocardiographic prediction of abnormal genotype in congenital long QT syndrome: experience in 101 related family members.  
  Kaufman ES, Priori SG, Napolitano C, Schwartz PJ, Iyengar S, Elston RC, Schnell AH, Gorodeski EZ, Rammohan G, Bahhur NO, Connuck D, Verrilli L, Rosenbaum DS, Brown AM, J Cardiovasc Electrophysiol 2001;12:455-461, 2001
• Heart rate variability in cocaine-exposed newborn infants.  
  Mehta SK, Super DM, Salvator A, Singer L, Connuck D, Fradley LG, Harcar-Sevcik RA, Kaufman ES, American Heart J 2001;142:828-32, 2001
• Influence of heart rate and sympathetic stimulation on arrhythmogenic T-wave alternans.  
  Kaufman ES, Mackall JA, Julka B, Drabek C, Rosenbaum DS, Am J Physiol Heart Circ Physiol 2000;279(3):H1248-H1255, 2000
• Novel characteristics of a misprocessed mutant HERG channel linked to hereditary long QT syndrome.  
  Ficker E, Thomas D, Viswanathan PC, Dennis AT, Priori SG, Napolitano C, Memmi M, Wible BA, Kaufman ES, Iyengar S, Schwartz PJ, Rudy Y, Brown AM, Am J Physiol Heart Circ Physiol 2000;279(4):H1748-H1756, 2000
• A comparison of T-wave alternans, signal averaged electrocardiography and programmed ventricular stimulation for arrhythmia risk stratification.  
  Gold MR, Bloomfield DM, Anderson KP, El-Sherif NE, Wilber DJ, Groh WJ, Estes NAM, Kaufman ES, Greenberg ML, Rosenbaum DS, J Am Coll Cardiol 2000;36:2247-53, 2000
• Passive head-up tilt and actively standing up produce similar overall changes in autonomic balance.  
  Bloomfield DM, Kaufman ES, Bigger JT Jr, Fleiss J, Rolnitzky L, Steinman R, Am Heart J 1997;134:316-320, 1997
• The relationship of autonomic function to age-related changes in left ventricular filling in normal subjects.  
  Finkelhor RS, Karwa P, Kaufman ES, Bahler RC, Eur Heart J 1995;16:1716-1720, 1995
• Join now to see all

Books/Book Chapters

• Electrophysiological disorders of the heart. 
  Chapter: Clinical use and mechanistic implications of microvolt T-wave alternans 
  Kaufman ES, Cutler M, Rosenbaum DSEditors: Saksena S & Camm AJ.Harcourt Health Sciences, New York, NY2012
• New Arrhythmia Technologies. 
  Chapter: Beta-blocker efficacy in long QT syndrome patients with mutations in the pore and nonpore regions of the hERG potassium-channel gene 
  Moss AJ, Peterson DR, Zareba W, Seth R, McNitt SA, Andrews ML, Qi M, Ackerman MJ, Benhorin J, Kaufman ES, Robinson JL, Towbin JA, Vincent GM, Zhang LEditors: Wang P, Naccarelli G, Rosen M, Estes M, Hayes D, and Haines H.Blackwell Publishing, Oxford, UK2005
• Oxford Textbook of Critical Care. 
  Chapter: ECG monitoring 
  Lewis, WR, Kaufman ESEditors: Webb A, Shapiro M, Singer M, and Suter P.Oxford University Press, Oxford, New York, Tokyo1999
• Textbook of Critical Care. 
  Chapter: Electrocardiography 
  Rakita L, Vrobel TR, Kaufman ESEditors: Shoemaker WC, Ayres SM, Grenvik A, and Holbrook PR.WB Saunders, PhiladelphiaEdition 3,1995
• Join now to see all

Abstracts/Posters

• Sodium channel mutations, risk of cardiac events and efficacy of beta-blocker therapy in type 3 long QT syndrome.
  Wilde AA, Kaufman ES, Shimizu W, Moss AJ, Benhorin J, Lopes CM, Towbin JA, Spazzolini C, Crotti L, Zareba W, Goldenberg I, Kanters JK, Robinson JL, Qi M, Hofman N, Tes..., Heart Rhythm 2012;9:S321, 2012
• Evidence for microvolt T-wave alternans as a mechanism for amplified spatial dispersion of repolarization in humans.
  Pasala T, Kaufman ES, Heart Rhythm 2011;8:S415, 2011
• Beta-blockers reduce Tpeak-end during exercise and recovery in patients with congenital long QT syndrome type 1.
  Gemma LW, Ward GM, Ball JL, Dettmer MM, Leo PJ, Doria DN, Kaufman ES, Heart Rhythm 2010;7:S173, 2010
• Effect of beta-blocker therapy on QT interval response to exercise in long QT syndrome type I and in healthy control subjects.
  Gemma LW, Ward GM, Ball JL, Dettmer MM, Leo PJ, Doria DN, Kaufman ES, Heart Rhythm 2009;6:S305, 2009
• Mild renal impairment adds prognostic value to MTWA and EPS in predicting ventricular tachyarrhythmias.
  Amit G, Kaufman ES, Rosenbaum DS, Costantini O, Heart Rhythm 2009;6:S21, 2009
• Potassium channel blockade unmasks LQT2 in congenital long QT syndrome.
  Kaufman ES, Abernethy DP, Natarajan RN, Meredith DM, Dettmer MM, Allareddy RR, Patel K, Jeyaraj D, Heart Rhythm 2006;3:S270, 2006
• Risk of death in the long QT syndrome when a sibling has died.
  Kaufman ES, Robinson JL, Andrews ML, Ackerman MJ, Zareba W, Moss AJ, Circulation 2005;112:II-396, 2005
• Evaluation of beta blocker therapy in the LQT3 form of long QT syndrome.
  Kaufman ES, Robinson JL, Andrews ML, Benhorin J, Ackerman MJ, Zareba W, Moss AJ, Circulation 2005;112:II-493, 2005
• “Indeterminate” T wave alternans test predicts high mortality risk in patients with impaired left ventricular function.
  Kaufman ES, Costantini O, Cohen RJ, Bloomfield DM, Steinman RC, Namerow PB, Bigger JT, Jr, Circulation 2005;112:II-531-532, 2005
• Prevalence of T wave alternans in the long QT syndrome population: a study involving 25 long QT syndrome families.
  Hassan MH, Kaufman ES, Heart Rhythm 2005;2:S303, 2005
• Patients with a nonischemic cardiomyopathy and a negative T-wave alternans stress test are at a low risk of death.
  Costantini O, Kaufman ES, Bloomfield DM, Steinman RC, Namerow PB, Parides MK, Bigger JT, Circulation 2004;110:III-667, 2004
• T wave alternans identifies low risk patients who may not benefit from ICD therapy.
  Bloomfield DM, Steinman RC, Namerow PB, Parides M, Kaufman ES, Curtis AB, Fontaine J, Russo AM, Bigger JT, Heart Rhythm 2004;1:S39, 2004
• T wave alternans predicts events independent of ejection fraction and etiology of heart disease in patients undergoing electrophysiologic testing for evaluation of kno...
  Bloomfield DM, Gold MR, Anderson KP, Wilber DJ, El-Sherif N, Estes M, Groh WJ, Kaufman ES, Greenberg ML, Rosenbaum DS, Dabbous OH, Cohen RJ, PACE 2000;23:59, 2003
• Location of mutation in the KCNQ1 gene does not influence outcome of long QT syndrome patients.
  Zareba W, Moss AJ, Sheu G, Kaufman ES, Robinson JL, Andrews ML, Carroll E, J Am Coll Cardiol 2003;41:273A, 2003
• Epinephrine unmasks the long QT phenotype in subjects with LQT1 genotype and normal ECG.
  Gorodeski EZ, Dikshteyn M, Dettmer MM, Kaufman ES, PACE 2003;26:999, 2003
• Female gender is not a risk factor for proarrhythmic events in the AFFIRM study: a multivariate analysis.
  Kaufman ES, Zimmerman PA, Wang T, Greene HL, Barrell PD and the AFFIRM Investigators, PACE 2003;26:975, 2003
• The occurrence and characteristics of stroke events in the AFFIRM study.
  Sherman DG, Kim S, Boop B, Corley S, DiMarco J, Hart RG, Haywood LJ, Hoyte K, Kaufman ES, Kim M, Nasco E, Waldo A, Neurology 2003;60:A326, 2003
• Three-year experience with mutation studies for the international long QT syndrome registry at Rochester: screening, molecular spectrum, mutation “hot-spots”, phenotyp...
  Qi M, Moss A, Ning L, Zareba W, Robinson J, Xu Y, Rosero S, Kaufman ES, Ohle C, Kelly T, Ryan D, Am J Hum Genet 2002;71S:549, 2002
• Repolarization variability in patients with congenital long QT syndrome.
  Perkiömäki JS, Zareba W, Nomura A, Andrews M, Kaufman ES, Moss AJ, Circulation 2001;104:II-691, 2001
• Microvolt level T-wave alternans is prevalent in a family with congenital long QT syndrome due to a HERG mutation.
  Kaufman ES, Gorodeski EZ, Koide NS, Verrilli LM, Rammohan G, Bahhur NO, Iyengar S, Napolitano C, Priori SG, J Am Coll Cardiol 2000;35:137A, 2000
• Heart rate variability measures are equivalent in genetically affected and unaffected members of a family with the long QT syndrome due to a HERG mutation.
  Kaufman ES, Rammohan G, Gorodeski EZ, Koide NS, Verrilli LM, Iyengar S, Napolitano C, Priori SG, J Am Coll Cardiol 2000;35:137A, 2000
• T-wave alternans bursting in patients at risk for sudden cardiac death.
  Kaufman ES, Julka B, Drabek C, Rosenbaum DS, J Am Coll Cardiol 2000;35:113A, 2000
• Prognostic Differences Between Patients with Atrial Flutter and Atrial Fibrillation.
  Quan KJ, Yuan Z, Kaufman ES, Lewis WR, Johnson NJ, Rimm AA, Biblo LA, PACE 1999;22:712, 1999
• Microvolt Level T- Wave Alternans is Prevalent in Subjects with Congenital Long QT Syndrome.
  Kaufman ES, Gorodeski EZ, Koide N, Verrilli LM, Rammohan G, Rosenbaum DS, J Am CollCardiol 1999;33:130A, 1999
• A Comparison of T Wave Alternans, Signal Averaged Electrocardiography and Electrophysiology Study to Predict Arrhythmia Vulnerability.
  Gold MR, Bloomfield DM, Anderson KP, Wilber DJ, El-Sherif N, Estes NAM III, Groh WJ, Kaufman E, Cohen RJ, J Am Coll Cardiol 1999;33:145A, 1999
• Join now to see all

Lectures

• Management of Atrial Fibrillation. 
  Multiple Locations, 1994, 1997
• Evaluation and Management of Syncope. 
  Multiple Locations, 1996, 1997
• Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death. 
  Multiple Locations, 1995, 1996
• Evaluation and Management of Supraventricular Tachycardia. 
  Multiple Locations, 1993, 1994
• The Evaluation and Management of Syncope. 
  Multiple Locations, 1995, 1997
• Pacemakers and ICDs Part II for cardiology fellows 
  2009, 2010, 2012
• Pacemaker and ICDs Part I for cardiology fellows. 
  2009, 2010, 2011
• Antiarrhythmic Drugs for cardiology fellows. 
  2009, 2010
• Management of Atrial Fibrillation, for Fellows. 
  1998, 1999
• Evaluation and Management of Syncope, Nuts and Bolts for Housestaff. 
  1996, 1998
• Recognition and Acute Management of Arrhythmias, Nuts and Bolts for Housestaff. 
  1997, 1998
• Recognition and Acute Management of Arrhythmias, Nuts and Bolts for Residents. 
  1994, 1995
• Syncope. 
  1991, 1993, 1994
• Evaluation of Families after Sudden Cardiac Death. 
  Medical Examiners’ Office, Cleveland - 4/2013
• Arrhythmia in Sarcoidosis. 
  Component of Cardiology Grand Rounds - 4/2013
• Genetic Aspects of Cardiac Disease Part II for Cardiology fellows. 
  4/2013
• Congenital Long QT Syndrome for fellows. 
  4/2013
• Pacemakers and ICDs for non-cardiologists. 
  4/2013
• Congenital Long QT Syndrome, Electrophysiology. 
  University Hospitals of Cleveland - 2/2013
• Utility of the ECG in Sudden Death Risk Stratification: T wave measures. 
  Heart Rhythm Society Annual Meeting, Denver - 2013
• Silent Atrial Fibrillation: What should we make of device-detected atrial high-rate episodes? 
  Cardiology Grand Rounds, MHMC - 11/2012
• Newest Approaches to the Long QT Syndrome 2nd Annual Newest Solutions for Cardiac Problems: An essential update for primary care physicians. 
  10/2012
• Antiarrhythmic Drugs for Atrial Fibrillation for cardiology fellows. 
  10/2012
• Genetic Aspects of cardiac disease, part II for cardiology fellows. 
  4/2012
• Update on the Long QT Syndrome. Arrhythmia Symposium for Women in Electrophysiology. 
  San Diego, CA - 2012
• Join now to see all